Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$342M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$300M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$270M |
| 4 |
Baker Hughes
BKR
|
+$249M |
| 5 |
Meta Platforms (Facebook)
META
|
+$220M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$650M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$424M |
| 3 |
Union Pacific
UNP
|
+$350M |
| 4 |
HES
Hess
HES
|
+$314M |
| 5 |
Deere & Co
DE
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.59% |
| 2 | Consumer Discretionary | 8.82% |
| 3 | Industrials | 8.12% |
| 4 | Financials | 7.95% |
| 5 | Healthcare | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Wheels Up
UP
$184M
| $240K | ﹤0.01% |
+4,188
| New | +$276K |
|
|
INZY
2302
DELISTED
Inozyme Pharma
INZY
| $240K | ﹤0.01% |
+31,380
| New | +$172K |
|
2303
Royal Bank of Canada
RY
$284B
| $239K | ﹤0.01% |
2,370
-42,088
| -95% | -$4.15M |
|
2304
ESCO Technologies
ESE
$7.14B
| $239K | ﹤0.01% |
2,233
-4,415
| -66% | -$453K |
|
2305
Fulgent Genetics
FLGT
$535M
| $239K | ﹤0.01% |
+10,994
| New | +$273K |
|
2306
PUT
United Parcel Service
UPS
$87.4B
| $238K | ﹤0.01% |
1,600
-300
| -16% | -$45.6K |
|
|
WNS
2307
DELISTED
WNS Holdings
WNS
| $237K | ﹤0.01% |
4,700
-1,554
| -25% | -$93.7K |
|
2308
Unifirst Corp
UNF
$5.28B
| $237K | ﹤0.01% |
1,368
-1,613
| -54% | -$274K |
|
2309
Apogee Therapeutics
APGE
$10.2B
| $237K | ﹤0.01% |
+3,561
| New | +$155K |
|
2310
INmune Bio
INMB
$65.5M
| $236K | ﹤0.01% |
20,047
-3,211
| -14% | -$38.8K |
|
2311
PUT
Tractor Supply
TSCO
$18.7B
| $236K | ﹤0.01% |
+4,500
| New | +$215K |
|
2312
Brown-Forman Class B
BF.B
$13.2B
| $234K | ﹤0.01% |
4,541
-3,842
| -46% | -$214K |
|
|
CRGX
2313
DELISTED
CARGO Therapeutics
CRGX
| $234K | ﹤0.01% |
+10,464
| New | +$249K |
|
2314
Metagenomi Therapeutics
MGX
$45.7M
| $232K | ﹤0.01% |
+22,009
| New | +$253K |
|
2315
Trinity Capital Inc
TRIN
$1.76B
| $232K | ﹤0.01% |
+15,793
| New | +$228K |
|
2316
Healthcare Services Group
HCSG
$1.56B
| $230K | ﹤0.01% |
18,454
-42,368
| -70% | -$470K |
|
|
PVBC
2317
DELISTED
Provident Bancorp
PVBC
| $230K | ﹤0.01% |
25,292
-15,707
| -38% | -$157K |
|
2318
NN Inc
NNBR
$301M
| $230K | ﹤0.01% |
+48,520
| New | +$223K |
|
|
ADTH
2319
DELISTED
AdTheorent Holding Co
ADTH
| $229K | ﹤0.01% |
+71,398
| New | +$195K |
|
2320
CALL
GE Aerospace
GE
$355B
| $228K | ﹤0.01% |
1,629
-6,014
| -79% | -$709K |
|
2321
Smith-Midland
SMID
$146M
| $227K | ﹤0.01% |
4,822
-3,650
| -43% | -$149K |
|
2322
Gaming and Leisure Properties
GLPI
$12.8B
| $226K | ﹤0.01% |
4,916
-1,152
| -19% | -$53K |
|
2323
Orion Group Holdings
ORN
$369M
| $226K | ﹤0.01% |
27,619
-1,999
| -7% | -$13K |
|
2324
Aemetis
AMTX
$136M
| $226K | ﹤0.01% |
37,710
-21,656
| -36% | -$82.2K |
|
|
VBTX
2325
DELISTED
Veritex Holdings
VBTX
| $224K | ﹤0.01% |
+10,943
| New | +$226K |
|
Similar funds
Dmitry Balyasny's Q1 2024 Portfolio in Review
As of Q1 2024, Dmitry Balyasny held 3,271 positions worth $57.2B, up 7.5% from $53.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dmitry Balyasny's Q1 2024 filing shows 835 new, 795 increased, 814 reduced and 718 closed positions. Its largest new stake was Public Service Enterprise Group: 2,419,537 shares worth $162M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $650M.
By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Dmitry Balyasny's largest Q1 2024 buy was Public Service Enterprise Group: 2,419,537 shares worth $162M.
- Dmitry Balyasny added most to Broadcom in Q1 2024, an estimated $342M increase.
- Dmitry Balyasny's biggest Q1 2024 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $650M.
- Dmitry Balyasny fully exited Splunk Inc in Q1 2024, selling an estimated $263M.
- Dmitry Balyasny's ten largest holdings make up 12% of its $57.2B portfolio in Q1 2024.
- Dmitry Balyasny opened 835 new positions and closed 718 in Q1 2024.
- Dmitry Balyasny's portfolio value rose 7.5% quarter-over-quarter to $57.2B.
Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.